Gefitinib | High-Quality Pharmaceutical Reference Standard
Gefitinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor used in the treatment of EGFR mutation–positive non-small cell lung cancer (NSCLC). It works by inhibiting EGFR signaling, reducing tumor cell proliferation and survival. Gefitinib API is manufactured under GMP-compliant conditions and is suitable for oral solid dosage formulations, including tablets.
Gefitinib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 6
